Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 7 recruiting now full pipeline

Postpartum Hemorrhage: full-pipeline trial registry

7 of 20 indexed Postpartum Hemorrhage trials are currently recruiting.

Corpus placement: #848 of 28,707 conditions by registered trial count.

20 US clinical trials · 7 currently recruiting · #848 of 28,707 conditions by registered trial count

Postpartum Hemorrhage: 20 US clinical trials tracked, 7 recruiting.

Postpartum Hemorrhage is the subject of 20 registered US clinical trials on ClinicalTrials.gov, 7 of them currently open to new participants. 5 are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most active sponsor is HemoSonics, running 2 of these trials.

Enrollment posture brief

Registry condition postpartum-hemorrhage

OPEN 7 | RECR 35% | LATE 5 | EARLY 5 | RANK #848 | SPON 2

Nearest open-share peer: Anatomic Stage IIIA Breast Cancer AJCC v8 (35% recruiting · 40 trials)

Advanced or Metastatic Solid55%ALS50%Postpartum Hemorrhage (this)35%Abdominal Pain25%Acute Myocardial Infarction25%
Open-enrollment share among volume-matched conditions near Postpartum Hemorrhage

Postpartum Hemorrhage lists 7 open slots (35% of 20 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Postpartum Hemorrhage on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Postpartum Hemorrhage is recruiting below its size-band peers.

    7 of 20 indexed trials (35%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Postpartum Hemorrhage trials is spread across many organizations.

    HemoSonics accounts for 2 of 20 trials (10%). 17 distinct sponsors appear on at least one study for this condition label.

  3. Typical Postpartum Hemorrhage enrolment sits around 107 participants.

    Median target enrolment is 107 among the 20 trials that report a genuine target (sentinel values excluded). 8 of those (40%) plan for fewer than 100 participants.

  4. Postpartum Hemorrhage research is mostly interventional.

    16 interventional and 4 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 24Phase 32Phase 43

Open and recent trials

20 total, page 1 of 1

RECRUITING NA 10,000 participants

A Pragmatic Randomized Controlled Trial to Predict Postpartum Hemorrhage

Holly Ende

NCT06513351

RECRUITING 1,725 participants

Postpartum Ultrasound Evaluation to Assess Risk of Hemorrhage

Endeavor Health

NCT06898034

RECRUITING Phase 3 1,358 participants

Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage

Stony Brook University

NCT05245227

RECRUITING 200 participants

Hemoglobin Testing in Pregnant Patients

George Washington University

NCT05977686

RECRUITING Phase 2 120 participants

Prevention of Postpartum Hemorrhage With Tranexamic Acid

Inova Health Care Services

NCT05370820

RECRUITING Phase 2 100 participants

Oxytocin Pharmacokinetics and Pharmacodynamics

University of Chicago

NCT05488457

RECRUITING NA 72 participants

Safety and Effectiveness of the KOKO Device to Treat Primary Abnormal Postpartum Uterine Bleeding or Hemorrhage

KOKO Medical

NCT06452355

COMPLETED 296 participants

QStat Cartridge in Obstetric Patients

HemoSonics

NCT06255496

COMPLETED NA 218 participants

Active Versus Expectant Management of the Third Stage of Labor

Christiana Care Health Services

NCT00473707

COMPLETED Phase 3 120 participants

Calcium Chloride for Prevention of Blood Loss During Intrapartum Cesarean Delivery

Stanford University

NCT05027048

COMPLETED Phase 2 110 participants

Tranexamic Acid for Prevention of Hemorrhage in Cesarean Delivery

University of Texas Southwestern Medical Center

NCT03856164

COMPLETED NA 107 participants

Safety and Effectiveness of the Jada System in Treating Primary Postpartum Hemorrhage

Alydia Health

NCT02883673

COMPLETED NA 104 participants

Postpartum Oxytocin Administration in the Era of Delayed Cord Clamping

Columbia University

NCT04632264

COMPLETED Phase 4 70 participants

Prospective Effect of Intravenous Ketorolac on Opioid Use, EBL and Complications Following Cesarean Delivery

University Hospitals Cleveland Medical Center

NCT02509312

COMPLETED Phase 4 66 participants

Prophylactic Methylergonovine for Twin Cesarean

Columbia University

NCT05772156

COMPLETED Phase 2 43 participants

Prevention of Postpartum Hemorrhage With Tranexamic Acid

George Washington University

NCT03287336

COMPLETED Phase 1 40 participants

A Study to Evaluate the Effect of Carbetocin on the QT/QTc Interval in Healthy Subjects

Ferring Pharmaceuticals

NCT05924321

COMPLETED NA 38 participants

Implementation of the NPMS Obstetric Hemorrhage Bundle at a Tertiary Center: Utilization of the Delphi Method

Brigham and Women's Hospital

NCT03018119

COMPLETED 22 participants

QStat in Trauma and Obstetric Hemorrhage

HemoSonics

NCT04385953

COMPLETED Phase 4 14 participants

Perioperative Administration of Tranexamic Acid for Placenta Previa and Accreta Study

University of California, San Francisco

NCT02806024

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 4
Phase 3 2
Phase 4 3

Named interventions

Most-linked intervention names on Postpartum Hemorrhage records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
4 trials
Tranexamic Acid Drug
3 trials
Jada System Device
1 trials
Quantra Hemostasis Analyzer with the QStat Cartridge Diagnostic test
1 trials
Oxytocin and gentle cord traction with fundal massage Drug
1 trials
Expectant management of the third stage of labor Procedure
1 trials
Active management of the third stage of labor Procedure
1 trials
Methylergonovine Drug
1 trials

US sites by state

Facility locations filed on Postpartum Hemorrhage trials. A trial with sites in several states counts in each.

New York 6 trials
Texas 4 trials
Ohio 4 trials
California 4 trials
Virginia 3 trials
Utah 3 trials
Illinois 3 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Postpartum Hemorrhage page

20 registered trials, 7 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 7 Postpartum Hemorrhage trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • HemoSonics sponsors the most Postpartum Hemorrhage trials on record, review their full trial history before evaluating a specific study. See HemoSonics's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Postpartum Hemorrhage condition card totals 20 registered trials; most-linked intervention Placebo; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.